The pharmacovigilance market refers to the activities and systems related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. Pharmacovigilance is critical to ensuring the safety of medications and reducing the risks associated with their use.
The market for pharmacovigilance is being driven by several factors, including the increasing number of adverse drug reactions (ADR), growing demand for pharmaceutical outsourcing, and the rising use of drugs in emerging economies. Additionally, the increasing adoption of electronic health records and the use of artificial intelligence in pharmacovigilance are also driving market growth.
See the detailed report:
https://www.fortunebusinessinsights.com/pharmacovigilance-pv-market-102746
The global “Pharmacovigilance Market” size is expected to reach USD 14.85 billion by 2028, exhibiting a CAGR of 13.1% during the forecast period, states Fortune Business Insights in a report titled “Pharmacovigilance Market, 2023-2028.” The market size stood at USD 5.56 billion in 2020.
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
- Key Opinion Leaders associated with Infinium Global Research
- Internal and External subject matter experts
- Professionals and participants from the industry
What is the goal of the report?
- The market report presents the estimated size of the market at the end of the forecast period. The report also examines historical and current market sizes.
- During the forecast period, the report analyses the growth rate, market size, and market valuation.
- The report presents current trends in the industry and the future potential of the North America, Asia Pacific, Europe, Latin America, and Middle East and African markets.
- The report offers a comprehensive view of the market based on geographic scope, market segmentation, and key player financial performance
List of Key Players Profiled in the Report:
- Parexel International Corporation (U.S.)
- Accenture plc (Ireland)
- Cognizant (U.S.)
- Bioclinica (U.S.)
- Pharmaceutical Product Development, LLC (U.S.)
- ICON plc (Ireland)
To get more information on the regional analysis of this market, Request a Free sample:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pharmacovigilance-pv-market-102746
Reasons for buying this report:
- It offers an analysis of changing competitive scenario.
- For making informed decisions in businesses, it offers analytical data with strategic planning methodologies.
- Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
- It offers a regional analysis of the Pharmacovigilance Market and several stakeholders' business profiles.
- It offers a six-year assessment of this market.
- It helps in understanding the major key product segments.
- It offers massive data about trending factors that will influence the progress of the Market
Table of content:
- Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
- Executive Summary
- Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Market Trends
Continuous…
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]
